Literature DB >> 11815620

A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets.

Paolo Lova1, Simona Paganini, Fabiola Sinigaglia, Cesare Balduini, Mauro Torti.   

Abstract

Stimulation of human platelets by cross-linking of the low affinity receptor for immunoglobulin, FcgammaRIIA, caused the rapid activation of the small GTPase Rap1B, as monitored by accumulation of the GTP-bound form of the protein. This process was totally dependent on the action of secreted ADP since it was completely prevented in the presence of either apyrase or creatine phosphate and creatine phosphokinase. Dose-dependent experiments revealed that the inhibitory effect of ADP scavengers was not related to the reduced increase of cytosolic Ca(2+) concentration in stimulated platelets. Activation of Rap1B induced by clustering of FcgammaRIIA was totally suppressed by AR-C69931MX, a specific antagonist of the G(i)-coupled ADP receptor P2Y12, but was not affected by blockade of the G(q)-coupled receptor, P2Y1. Similarly, direct stimulation of platelets with ADP induced the rapid activation of Rap1B. Pharmacological blockade of the P2Y1 receptor totally prevented ADP-induced Ca(2+) mobilization but did not affect activation of Rap1B. By contrast, prevention of ADP binding to the P2Y12 receptor totally suppressed activation of Rap1B without affecting Ca(2+) signaling. In platelets stimulated by cross-linking of FcgammaRIIA, inhibition of Rap1B activation by ADP scavengers could be overcome by the simultaneous recruitment of the G(i)-coupled alpha(2A)-adrenergic receptor by epinephrine. By contrast, serotonin, which binds to a G(q)-coupled receptor, could not restore activation of Rap1B. When tested alone, epinephrine was found to be able to induce GTP binding to Rap1B, whereas serotonin produced only a slight effect. Finally, activation of Rap1B induced by stimulation of the G(q)-coupled thromboxane A(2) receptor by was completely inhibited by ADP scavengers under conditions in which intracellular Ca(2+) mobilization was unaffected. Inhibition of -induced Rap1B activation was also observed upon blockade of the P2Y12 but not of the P2Y1 receptor for ADP. These results demonstrate that stimulation of a G(i)-dependent signaling pathway by either ADP of epinephrine is necessary and sufficient to activate the small GTPase Rap1B.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815620     DOI: 10.1074/jbc.M111803200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Rap1-Rac1 circuits potentiate platelet activation.

Authors:  Lucia Stefanini; Yacine Boulaftali; Timothy D Ouellette; Michael Holinstat; Laurent Désiré; Bertrand Leblond; Patrick Andre; Pamela B Conley; Wolfgang Bergmeier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 2.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

3.  Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling.

Authors:  Guoying Zhang; Binggang Xiang; Shaojing Ye; Magdalena Chrzanowska-Wodnicka; Andrew J Morris; T Kent Gartner; Sidney W Whiteheart; Gilbert C White; Susan S Smyth; Zhenyu Li
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

4.  The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3.

Authors:  Bruno Bernardi; Gianni F Guidetti; Francesca Campus; Jill R Crittenden; Ann M Graybiel; Cesare Balduini; Mauro Torti
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

Review 5.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy.

Authors:  Moritz Stolla; Lucia Stefanini; R Claire Roden; Massiel Chavez; Jessica Hirsch; Teshell Greene; Timothy D Ouellette; Sean F Maloney; Scott L Diamond; Mortimer Poncz; Donna S Woulfe; Wolfgang Bergmeier
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

7.  A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration.

Authors:  Peter Schubert; Jonathan N Thon; Geraldine M Walsh; Cindy H I Chen; Edwin D Moore; Dana V Devine; Juergen Kast
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

8.  Phosphoinositide 3-kinase p110 beta regulates integrin alpha IIb beta 3 avidity and the cellular transmission of contractile forces.

Authors:  Simone M Schoenwaelder; Akiko Ono; Warwick S Nesbitt; Joanna Lim; Kate Jarman; Shaun P Jackson
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

9.  Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Authors:  Fadila Guessous; Marek Marcinkiewicz; Renata Polanowska-Grabowska; Sudawadee Kongkhum; Daniel Heatherly; Tom Obrig; Adrian R L Gear
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

10.  Association analysis of member RAS oncogene family gene polymorphisms with aspirin intolerance in asthmatic patients.

Authors:  Jong-Sook Park; Jeong-Seok Heo; Hun Soo Chang; Inseon S Choi; Mi-Kyeong Kim; Jong-Uk Lee; Byung Lae Park; Hyoung Doo Shin; Choon-Sik Park
Journal:  DNA Cell Biol       Date:  2014-02-20       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.